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Abstract
Background: Malaria during pregnancy remains a serious public health problem. The aim of this study was to
determine the prevalence and possible risk factors for malaria in pregnant women attending antenatal clinic at two
primary health facilities in Bobo-Dioulasso.
Methods: We conducted a cross sectional study from September to December 2010 in two primary health facilities
located in the periurban area of Bobo-Dioulasso. Pregnant women attending antenatal clinic (ANC) were included
in the study after signing informed consent. For each participant, the social-demographic profile, malaria and
obstetric histories were investigated through a questionnaire. Peripheral blood was collected and thick and thin
blood smears were prepared to check Plasmodium falciparum parasitaemia. Hemoglobin concentration was
measured. The associations between age, parity, gestational age, schooling, number of ANC visits, use of IPTp-SP, use
of insecticide-treated nets (ITN) and anemia with the occurrence of P. falciparum malaria infection during pregnancy
were analyzed through logistic regression.
Results: During the period of study, 105 (18.1%) out of 579 pregnant women were infected by P. falciparum. The
hemoglobin concentration mean was 10.5 ± 1.7/dL and was significantly lower in pregnant women with malaria
infection (9.8 g/dL ±1.6) than in those who had no malaria infection (10.6 g/dL ±1.7) (P < 0.001). Multivariate
analysis indicated that, education (AOR 1.9, 95% CI = [1.2-3.2]), parity [primigravidae (AOR 5.0, 95% CI = [2.5-9.8]) and
secundigravidae (AOR 2.1, 95% CI = [1.2-3.8])], and anaemia (AOR 2.1, 95% CI = [1.3-3.5]) were significantly associated
with P. falciparum malaria infection. The use of IPTp-SP was not associated with P. falciparum malaria infection.
Conclusions: P. falciparum malaria infection is common in pregnant women attending antenatal clinic and anaemia is
an important complication. The results show that the use of IPTp-SP does not reduce the risk of malaria incidence
during pregnancy.
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Background
Malaria during pregnancy is a serious public health
problem in Sub-Saharan Africa. It is estimated that each
year, approximately 25 million pregnant women in
Sub-Saharan Africa are at risk of Plasmodium falciparum
malaria infection during pregnancy [1]. Malaria during
pregnancy leads to serious adverse effects on the mother
and the child. Indeed although malaria during pregnancy
might be asymptomatic due to high level of acquired im-
munity in mothers residing in high transmission areas, it
is still associated with maternal anaemia, abortion, prema-
turity and low birth weight [1,2]. Moreover, severe mater-
nal anaemia increases the mother’s risk of death and
malaria related anaemia is estimated to cause as many as
10,000 maternal death each year in Africa [3]. In Burkina
Faso, 22,130 cases of severe malaria were recorded during
pregnancy in 2011 resulting in 97 maternal deaths [4].
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To face this flail, the World Health Organization
(WHO) adopted the intermittent preventive treatment
with sulfadoxine-pyrimethamine during pregnancy (IPTp-
SP) [3]. This policy has been adopted by the Burkina Faso
ministry of health in 2005. Several epidemiological studies
have been conducted in pregnancy before and after the
implementation of IPTp-SP in Burkina Faso [5-17]. The
prevalence of maternal peripheral P. falciparum infection
assessed by microscopy was 24% in urban area [12] and
varied from 19.4% to 50.8% in rural area [5-9,13].
Factors influencing malaria prevalence in pregnant
women include maternal age, parity, use of prophylaxis,
nutrition, host and parasite genetics and level of anti-
parasitic immunity [18] with conflicting data concerning
maternal age and parity depending on urban or rural set-
ting [19-23]. So far, only one study had investigated the risk
factors of malaria during pregnancy in Burkina Faso [5].
This study had been carried out in a rural area and one year
after the implemention of IPTp-SP pilot program.
Understanding the epidemiology of malaria during
pregnancy facilitates decision on control strategies.This
study aimed to assess the prevalence of P. falciparum
malaria infection and possible associated risk factors in
pregnant women attending antenatal clinic in the periurban
area of Bobo-Dioulasso.
Methods
Study site and study design
A cross sectional study was performed from September
to December 2010 in Lafiabougou and Kua two primary
health facilities both located in the periurban area of
Bobo-Dioulasso (Burkina Faso). In this area, the high
transmission season of malaria lasts 4 months from
August to November. The entomological inoculation
rate (EIR) was about 63 infective bites per habitant per
year "unpublished observations".
Data collection
All pregnant women presenting for their routine antenatal
clinic visits were included in the study after explaining
to them the purpose of the study and signing informed
consent. Each participant was evaluated only once. Data
were obtained through a questionnaire and included the
following information: social-demographic profile, malaria
history, obstetric history including parity, gestational age.
Gestational age was calculated from the first day of
bleeding of the last menstrual period. Only two pregnant
women refused to participate to the study because their
husband did not allow them to participate to the study.
Laboratory methods
Blood samples were taken by finger prick for checking
both malaria parasite and hemoglobin concentration.
Blood smear and thick drop assays were stained with
10% Giemsa dye. Smears were fixed with May Grunvald
for three minutes before staining with Giemsa for
20 minutes. Parasite density was determined by counting
asexual forms of the parasite per 200 leukocytes assuming
8,000 leukocytes/μL of blood. A slide was considered
negative if no parasite was found after counting 500
leukocytes. All the slides were double-checked blindly
and for discrepant results a third consensus reading
was performed.
Hemoglobin concentration was determined by the hematic
acid method using a hemoglobinometer (HemoCue
AB, Angelhom, Sweden) and were classified as anemia
(<11 g/dL), severe anemia (<8 g/dL) and normal
(≥11 g/dL) [10].
Sample size
The sample size calculation was based on an assumed
prevalence of malaria in pregnant women attending
antenatal clinic and benefiting from IPT-SP of 13.8% [5],
a precision of 5% and for a significant result at the 5%
level. A sample of 193 pregnant women was needed. Then
we sampled 193 pregnant women in each trimester of
pregnancy resulting a total size of 579 pregnant women.
Statistical analysis of data
Data were double entered in EpiData 3.1 software and
analyzed by using Stata 12 soſtware.
The prevalence of P. falciparum malaria infection has
been estimated with a 95% confidence interval (CI).
Univariate analyses were performed by using the Pearson
Chi-square or Fisher’s exact tests to compare proportions
for categorical variables. Comparison between continuous
variables with normal distributions including age and
hemoglobin concentration was done by the Student’s
t-test or the Anova test. The Wilcoxon rank sum test
and the Kruskall-Wallis test were used to compare con-
tinuous variables with non-normal distributions (parasite
density and number of ANC visits).
Simple and multiple logistic regression models were
also used as described below. The variable malaria
(including with and without P. falciparum malaria in-
fection categories) was considered as the dependent
variable. The independent variables included age,
schooling, gestational age, parity, use of IPTp-SP and
insecticide-treated net (ITN) during pregnancy, number
of ANC visits and anaemia. Variables were categorized as
follows: age (<20 years old, ≥20 years old); parity as primi-
gravidae, secundigravidae, multigravidae (≥3); gestational
age [first trimester (<14 weeks), second trimester (14–27
weeks) and third trimester (≥28 weeks)], number of ANC
visits (0–1, 2 and ≥3). To investigate the association be-
tween the several independent variables and malaria, we
began by performing simple logistic regressions with each
independent variable. Next, we applied multiple regression
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models to control possible confusion. Variables exhibiting
statistically significant associations (p < 0.05) or with im-
portant epidemiological meanings were included. These
co-variables were kept in models, independent of their
significance, in univariate analysis due to their possible
relevance in the final results; thus, we could analyze
their possible influence when considered together with
the other variables.
Ethical considerations
The study was initially discussed with health authorities
and community leaders to obtain their assent. This study
was approved by the National Ethics Committee for health
research, Ouagadougou Burkina Faso (number 2010–054).
A written informed consent was obtained from all preg-
nant prior to their enrolment in the study. For illiterate
pregnant women, the informed consent discussion process
was witnessed by an impartial individual. In those
cases, the informed consent form had been signed with
a thumbprint.
All women with anaemia or positive for malaria have
been treated orally with folic acid plus ferrous and quinine
300 mg (24 mg/day until 7 days), respectively.
Results
Baseline characteristics of pregnant women attending
antenatal clinic
The baseline characteristics of the 579 pregnant women
involved in the study are summarized in Table 1. Briefly,
the pregnant women were young (24.7 years ±5.7) and
most of them had no formal education (61.1%), and were
multigravidae (44.7%). Moreover 46.9% and 26.7% of
pregnant women benefited from ITN and at least two
doses of IPTp-SP, respectively. The proportion of preg-
nant women receiving the recommended 2 or 3 doses of
IPTp-SP was higher during the 3rd trimester (p < 0.001).
Of the 579 participating women, 50.4% reported attend-
ing ANC at least once during their pregnancy. The
number of ANC visits varied from 0 to 2 with a median
of 2 visits. Among ANC attendees, majority (39.9%)
made their first visit during the second trimester. Only
2.8% of the ANC attendees had complete attendance
(considered to be at least four ANC visits during preg-
nancy). The prevalence of P. falciparum parasitaemia
was 18.1% (95% CI = [15.1-21.2]) and the geometric mean
of the parasite density (GMPD) was 2254 parasites/μL
(95% CI = [1755–2894]). The geometric mean of the
density of P. falciparum parasitaemia was signifi-
cantly lower in pregnant women who had used IPTp-SP
(P <0.001). The haemoglobin concentration mean was sig-
nificantly lower in pregnant women with malaria infection
(9.8 g/dL ±1.6) than in those who had no malaria infection
(10.6 g/dL ±1.7) (P <0.001).
IPTp-SP uptake at ANC clinic
The proportion of women receiving the recommended 2
or 3 doses of IPTp-SP increased (p < 0.001) with the
number of ANC visits attended (Table 2).
Factors associated with malaria among pregnant women
attending antenatal clinic
Multivariate analysis indicated that, lower level of educa-
tion (AOR 1.9, 95% CI = [1.2-3.2]), parity [primigravidae
(AOR 5.0, 95% CI = [2.5-9.8]) and secundigravidae (AOR
2.1, 95% CI = [1.2-3.8])], and anaemia (AOR 2.1, 95% CI =
[1.3-3.5]) were significantly associated with P. falciparum
malaria infection. The use of IPTp-SP was not associated
with P. falciparum malaria infection (Table 3).
Discussion
This study aimed to assess the prevalence of P. falciparum
malaria infection and possible associated risk factors in
pregnant women attending ANC in the periurban area of
Bobo-Dioulasso. The prevalence of maternal peripheral P.
falciparum infection assessed by microscopy was 24% in
urban area [12] and varied from 19.4% to 50.8% in rural
area [5-9,13]. An additional file shows this in more detail
[see Additional file 1]. The higher observed rates in rural
area could be explained by the high transmission level of
malaria in rural area of Burkina Faso (unpublished obser-
vations). The difference between our results with those
reported in Ouagadougou, the capital of Burkina Faso [12]
could be due to the lower use of IPTp-SP in that study.
Our rate was higher compared to that found in the rural
area of Ghana in 2012 [24]. Indeed, all pregnant women
included in the Ghanaian study had benefited from at least
2 doses IPTp-SP. A prevalence of 10.9% was found in
Luanda, Angola, an urban site with similar malaria
epidemiological characteristics [25] even though the
survey had been conducted during high the transmission
season of malaria. Our findings about the prevalence of
malaria may be underestimated due to the use of micros-
copy of Giemsa-stained blood smears of peripheral blood
for diagnosis. The use of PCR could have improved the
sensitivity and specificity of the diagnosis as previously
reported in Burkina Faso [13] nevertheless the high micro-
scopic prevalence is of serious concern.
This study showed that lack of formal education was a
risk factor for P. falciparum malaria.This agrees with
previous findings in India [26] and highlights the need
of more sensitization to increase the use of malaria
prevention measures. Parity was associated with malaria
infection even adjusted for age as previously shown [5].
Association between the decrease in risk of malaria infec-
tion and parity has been reported in several studies
[27,28]. However, in none of these studies, the association
between parity and malaria infection was adjusted for
women’s age. A common explanation of the association
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between malaria infection and parity is that pregnancy is
associated with a decrease in immunity [2]. In Mali, parity
was significantly associated with malaria infection only
when the analysis was not adjusted for age [21]. Other
authors found no association between parity and malaria
infection [19,23,25]. In the present study and as well as in
that of Adam et al. [23], age was not significantly associ-
ated with malaria infection in contrast to the previous ob-
servations [19,21,22]. Previous sulfadoxine-pyrimethamine
chemoprophylaxis was not associated with the prevalence
of malaria infection when adjusted for different factors.
In addition the coverage of the recommended 2 or 3
IPTp-SP among the 3rd trimester women was very low
(49.2%) but it is higher than the recent reported cover-
age (10-19%) for Burkina Faso [29].
Table 2 Distribution of IPTp-SP doses according to the
number of ANC visits
Characteristics Number of ANC visits P
0-1 2 ≥ 3
IPTp-SP doses
0 351 (85.2) 1 (0.9) 0 (0.0) <0.001f
1 59 (14.3) 53 (49.1) 12 (20.3)
≥ 2 2 (0.5) 54 (50.0) 47 (79.7)
fDetermined by Chi-square (Fischer exact) Test.
Table 1 Baseline characteristics of pregnant women attending ANC in Bobo-Dioulasso
Characteristics Total 1st 2nd 3rd P
(n = 579) Trimester (n = 193) Trimester (n = 193) Trimester (n = 193)
Mean age (year), 24.7 ± 5.7 24.5 ± 5.7 24.2 ± 5.4 25.4 ± 5.8 0.09a
± SD
< 20 108 (18.6) 41 (21.2) 39 (20.2) 28 (14.5) 0.2p
≥ 20 471 (81.4) 152 (78.8) 154 (79.8) 165 (85.5)
Education 0.5p
No formal schooling 353 (61.1) 113 (58.5) 124 (64.6) 116 (60.1)
Formal schooling 225 (38.9) 80 (41.5) 68 (35.4) 77 (39.9)
Parity 0.01p
Primigravidae 170 (29.4) 72 (37.3) 61 (31.6) 37 (19.1)
Secundigravidae 150 (25.9) 43 (22.3) 48 (24.9) 59 (37.6)
Multigravidae 259 (44.7) 78 (40.4) 84 (43.5) 97 (50.3)
ITN Use or ownership 271 (46.9) 90 (46.9) 91 (47.2) 90 (46.6) 0.9p
ANC visits
Median, quartiles 2 (0–2) - 1 (1–2) 2 (1–3) <0.001w
No prior ANC visit 287 (49.6) 190 (98.5) 88 (45.6) 9 (4.7)
1 125 (21.6) 3 (1.5) 77 (39.9) 45 (23.3) <0.001f
2 108 (18.6) 0 (0.0) 24 (12.4) 84 (43.5)
≥ 3 59 (10.2) 0 (0.0) 4 (2.1) 55 (28.5)
Doses of IPTp-SP
0 352 (60.8) 193 (100.0) 139 (72.0) 20 (10.4) <0.001f
1 124 (21.4) 0 (0.0) 46 (23.8) 78 (40.4)
≥ 2 103 (17.8) 0 (0.0) 8 (4.2) 95 (49.2)
Peripheral parasitaemia 105 (18.1) 46 (23.8) 37 (19.2) 22 (11.4) 0.006p
GMPD/μL, 2254 2300 1886 2913 0.3k
[95% IC] [1755–2894] [1600–3008] [1253–2839] [1475–5757]
Mean haemoglobin (g/dL), ± SD 10.5 ± 1.7 11.0 ± 1.7 10.1 ± 1.6 10.3 ± 1.7 <0.001a
Anaemia (% Hb <11 g/dL) 346 (60.0) 90 (46.9) 132 (68.4) 124 (64.6) <0.001p
Moderate to severe anaemia (% Hb <8 g/dL) 37 (6.4) 5 (2.6) 17 (8.8) 15 (7.8) 0.03p
aDetermined by Anova Test. pDetermined by Pearson Chi-square Test.
fComparison between 2nd and 3rd trimester determined by Chi-square (Fischer exact) Test.
wDetermined by Wilcoxon rank sum Test. kDetermined by Kruskal-Wallis Test.
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Furthermore only 46.6% of them reported ITN owner-
ship. All these findings together highlight the WHO 2004
malaria prevention program failure and suggest the need
to replace SP. However is it worth replacing SP when the
WHO goal of four ANC visits [3] during pregnancy is not
yet achieved? Indeed, the majority of the 3rd trimester
women (71.5%) have attended less than three ANC visits.
This is of serious concern because the cost of an ANC
consultation is officially free of charge in Burkina Faso.
The lower level of education of pregnant women could
have contributed to the low level of correct ANC attend-
ance. Thus educating pregnant women on focused ANC
visits is recommended. Moreover the whole health system
needs to be revitalized including antenatal care staffs that
also need to be educated and enthused so that they can
explain to women to try to meet the number of visits; the
government needs to support access to antenatal care in
rural areas.
The coverage of the recommended SP dosage increased
with the number of ANC visits as previously reported in
Benin [30] and in Cameroon [31]. However in Gabon,
almost 40% of delivering women with more than three
ANC visits had no or partial SP uptake [32].
This suggests that the number of ANC visits does not
necessarily ensure the complete IPTp- SP coverage.
Indeed, it has been shown that the coverage of IPTp-
SP increases and ANC attendance is substantial when
SP is supervised [32]. Thus further studies are needed
to explore barriers to complete IPTp-SP coverage in
Bobo-Dioulasso.
The mean haemoglobin was significantly lower in
women with malaria infection. This agrees with findings
Table 3 Risk factors associated with malaria among pregnant women attending ANC in Bobo-Dioulasso
Potential factors Malaria Crude OR Adjusted OR P
[95% IC] [95% IC]
Age
≥ 20 years 17.0 (80/471) 1 1 -
< 20 years 23.1 (25/108) 1.5 [0.9-2.4]* 1.6 [0.8-3.2] 0.2
Education
Formal schooling 19.8 (70/353) 1 1 -
No formal schooling 15.6 (35/225) 1.3 [0.9-2.1]* 1.9 [1.2-3.2] 0.01
Gestational age
3rd trimester 11.4 (22/193) 1 1 -
2nd trimester 19.7 (37/193) 1.8 [1.04-3.3] 0.7 [0.3-1.5] 0.4
1st trimester 23.8 (46/193) 2.4 [1.4-4.23] 0.8 [0.3-1.9] 0.6
Parity
Multigravidae 11.2 (29/259) 1 1 1
Secundigravidae 18.0 (27/150) 1.7 [0.9-3.1] 2.1 [1.2-3.8] 0.02
Primigravidae 28.8 (49/170) 3.2 [1.9-5.3] 5.0 [2.5-9.8] <0.001
ANC visits
0-1 22.3 (92/412) 1 1 1
2 4.6 (5/108) 0.2 [0.1-0.4] 0.3 [0.1-1.0] 0.05
≥ 3 13.6 (8/59) 0.5 [0.2-1.2] 1.3 [0.3-5.2] 0.7
IPTp-SP dose
0 23.4 (83/352) 1 1 -
1 11.3 (14/124) 0.4 [0.2-0.8] 0.5 [0.2-1.2] 0.1
≥ 2 7.8 (8/103) 0.3 [0.1-0.6] 0.3 [0.1-1.5] 0.1
ITN
No 20.9 (64/307) 1 1 1
Yes 14.8 (40/271) 0.7 [0.4-1.0] 0.8 [0.5-1.5] 0.4
Anaemia
No 12.5 (29/231) 1 1 1
Yes 21.7 (76/346) 2.0 [1.2-3.1] 2.1 [1.3-3.5] 0.003
*P value =0.2.
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not only in areas of stable transmission of malaria [25,33]
but also in areas with unstable transmission [23,34].
Anaemia was the main complication of malaria infec-
tion found in our study and remains the most frequent
consequence of malaria during pregnancy irrespective
of transmission level and pre-pregnancy level of malaria
immunity [35].
Conclusion
Our results suggest that P. falciparum is common in preg-
nant women attending antenatal clinic in Bobo-Dioulasso
and that anemia is an important complication associated
with P. falciparum infection. Lack of formal education
and parity even adjusted for age are main risk factors
for malaria. The use of IPTp-SP was not associated with
P. falciparum malaria infection.
Additional file
Additional file 1: Prevalence of maternal peripheral P. falciparum
infection from 2004 to 2011 in Burkina Faso. The data provided show
the prevalence of maternal peripheral P. falciparum infection reported in
Burkina Faso, organized by type of study, period of study, location,
pregnant women’s data including age and parity.
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